Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Total Debt Over TimeElevated
Percentile Rank78
3Y CAGR+17.1%
5Y CAGR+6.3%
Studio
Year-over-Year Change

Sum of short-term and long-term debt obligations

3Y CAGR
+17.1%/yr
Annual compound
5Y CAGR
+6.3%/yr
Recent acceleration
Percentile
P78
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineElevated
PeriodValueYoY Change
2025$9.50M-3.6%
2024$9.86M-19.6%
2023$12.26M+107.1%
2022$5.92M-2.2%
2021$6.05M-13.4%
2020$6.99M+163.4%
2019$2.65M-
2018$0.00-
2017$0.00-
2016$0.00-